BALA CYNWYD, Pa., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
Ra Medical Systems, Inc. (NYSE American - RMED)
Under the terms of the agreement, Ra Medical will merge with Catheter Precision, Inc. (“Catheter Precision”). The transaction will be a stock for stock reverse merger whereby all of Catheter Precision’s outstanding convertible promissory notes and equity interests are to be exchanged for shares of Ra Medical common stock and Catheter Precision options assumed by the Company. Catheter Precision stakeholders are expected to own approximately 80% of the combined company, and pre-merger Ra Medical equity holders are expected to own approximately 20% of the combined company. The investigation concerns whether the Ra Medical Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution to the Company’s shareholders in the combined company.
Additional information can be found at https://www.brodskysmith.com/cases/ra-medical-systems-inc-nyse-american-rmed/.
Brigham Minerals, Inc. (NYSE - MNRL)
Under the terms of the agreement, Brigham Minerals will merge with Sitio Royalties Corp. (“Sitio”) (NYSE - STR). Brigham Minerals shareholders will receive a fixed exchange ratio of 1.133 shares of common stock in the combined company for each share of Brigham common stock owned on the closing date. Upon completion of the transaction, Sitio shareholders will own approximately 54.0% and Brigham shareholders will own approximately 46.0% of the combined entity on a fully diluted basis. The investigation concerns whether the Brigham Minerals Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution to the Company’s shareholders in the combined company.
Additional information can be found at https://www.brodskysmith.com/cases/brigham-minerals-inc-nyse-mnrl/ .
Signify Health, Inc. (NYSE - SGFY)
Under the terms of the merger agreement, Signify Health will be acquired by CVS Health® (NYSE - CVS). Signify Health shareholders will receive $30.50 in cash for each share of the Company they own, representing a total transaction value of approximately $8 billion. The investigation concerns whether the Signify Health Board breached its fiduciary duties to shareholders by failing to conduct a fair process, and whether CVS Health® is paying too little for the Company.
Additional information can be found at https://www.brodskysmith.com/cases/signify-health-inc-nyse-sgfy/.
ChannelAdvisor Corporation (NYSE - ECOM)
Under the terms of the agreement, ChannelAdvisor will be acquired by CommerceHub. ChannelAdvisor shareholders will receive $23.10 in cash for each share of the Company they own. The investigation concerns whether the ChannelAdvisor Board breached its fiduciary duties to shareholders by failing to conduct a fair process, and whether CommerceHub is paying too little for the Company. For example, the deal consideration is below the 52-week high of $29.42 for the Company’s shares.
Additional information can be found at https://www.brodskysmith.com/cases/channeladvisor-corporation-nyse-ecom/.
Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.
